BeStock  

Cooper Companies COO

US equityMarket cap rank #1319Medical Instruments & Supplies
$58.88 −$1.45 (-2.40%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $59.53 +1.10%
Open$60.67
Prev close$60.33
Day range$58.66 – $60.98
Volume2.08M
Market cap$11.20B
P/E (TTM)20.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Jul 2026

Revenue$1.07B+0.6% YoY
Operating profit$222.00M+26.4% YoY
Net profit$432.80M+340.3% YoY
Diluted EPS$2.24+357.1% YoY
Free cash flow$273.00M+66.0% YoY
Operating cash flow$341.70M

Revenue, last 8 quarters

$1.0BOct '24$964.7MJan '25$1.0BApr '25$1.1BJul '25$1.1BOct '25$1.0BJan '26$1.1BApr '26$1.1BJul '26

Net profit, last 8 quarters

$117.5MOct '24$104.3MJan '25$87.7MApr '25$98.3MJul '25$84.6MOct '25$130.8MJan '26$-77.9MApr '26$432.8MJul '26

Diluted EPS by quarter

0.58Oct '240.52Jan '250.44Apr '250.49Jul '250.43Oct '250.66Jan '26-0.40Apr '262.24Jul '26

Free cash flow by quarter

$128.1MOct '24$101.2MJan '25$18.1MApr '25$164.5MJul '25$149.9MOct '25$158.7MJan '26$96.4MApr '26$273.0MJul '26

Annual revenue

$2.4BFY20$2.9BFY21$3.3BFY22$3.6BFY23$3.9BFY24$4.1BFY25

Profitability & balance sheet

Gross margin65.9%
Operating margin12.8%
Net margin13.5%
Return on equity6.8%
Return on assets4.6%
Return on invested capital5.7%
Current ratio1.22
Liabilities / assets34.3%
Cash & investments$154.70M
Total debt$2.54B
Net cash (debt)-$2.39B
Free cash flow / sales16.0%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • CooperVision$717.00M 67.2%
  • CooperSurgical$349.20M 32.8%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.07B $1.08B $1.02B $4.09B $1.07B
Total Operating Revenue $1.07B $1.08B $1.02B $4.09B $1.07B
Cost of Revenue $354.30M $346.10M $328.90M $1.41B $414.30M
Gross Profit $711.90M $735.40M $695.20M $2.68B $650.80M
Operating Expense $489.90M $766.40M $482.40M $2.00B $510.40M
Selling and Admin Expenses $401.30M $676.20M $390.20M $1.63B $419.20M
Research & Development $41.60M $42.50M $44.30M $172.20M $41.40M
Depreciation & Amortization & Depletion $47.00M $47.70M $47.90M $199.20M $49.80M
-Depreciation & Amortization $47.00M $47.70M $47.90M $199.20M $49.80M
Operating Profit $222.00M -$31.00M $212.80M $682.90M $140.40M
Net Non-Operating Interest Income (Expense) -$21.50M -$20.90M -$22.40M -$100.00M -$24.40M
Non-Operating Interest Expense $21.50M $20.90M $22.40M $100.00M $24.40M
Other Income (Expense) $1.30M $3.50M $1.80M -$16.40M $800,000.00
Gain on Sale of Security -$3.20M -$800,000.00 -$1.30M -$8.00M -$2.30M
Other Non-Operating Income (Expenses) $4.50M $4.30M $3.10M -$8.40M $3.10M
Pretax Profit $201.80M -$48.40M $192.20M $566.50M $116.80M
Tax -$231.00M $29.50M $61.40M $191.60M $32.20M
Net Profit $432.80M -$77.90M $130.80M $374.90M $84.60M
Profit from Continuing Operations $432.80M -$77.90M $130.80M $374.90M $84.60M
Net Income to Parent Company $432.80M -$77.90M $130.80M $374.90M $84.60M
Net Income to Common Stockholders $432.80M -$77.90M $130.80M $374.90M $84.60M
Basic EPS $2.24 -$0.40 $0.67 $1.88 $0.43
Diluted EPS $2.24 -$0.40 $0.66 $1.87 $0.43
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $12.67B $12.48B $12.42B $12.39B $12.39B
Total Current Assets $2.28B $2.30B $2.13B $2.11B $2.11B
Cash and Cash Equivalents & Short-Term Investments $154.70M $138.80M $124.90M $110.60M $110.60M
-Cash and Cash Equivalents $154.70M $138.80M $124.90M $110.60M $110.60M
Receivables $788.90M $809.20M $807.10M $829.00M $829.00M
-Accounts Receivable $788.90M $809.20M $807.10M $829.00M $829.00M
Inventory $911.50M $896.40M $876.40M $846.00M $846.00M
Other Current Assets $426.40M $455.40M $325.40M $320.80M $320.80M
Total Non-Current Assets $10.39B $10.18B $10.29B $10.29B $10.29B
Net PPE $2.14B $2.13B $2.12B $2.08B $2.08B
Goodwill and Other Intangible Assets $5.32B $5.38B $5.45B $5.44B $5.44B
-Goodwill $3.88B $3.89B $3.91B $3.85B $3.85B
-Other Intangible Assets $1.45B $1.49B $1.54B $1.59B $1.59B
Non-Current Deferred Assets $2.27B $1.99B $2.04B $2.08B $2.08B
Other Non-Current Assets $656.90M $672.80M $688.40M $689.20M $689.20M
Total Liabilities $4.35B $4.24B $4.06B $4.16B $4.16B
Total Current Liabilities $1.87B $1.80B $1.60B $1.11B $1.11B
Payables $251.20M $233.30M $225.80M $300.40M $300.40M
-Accounts Payable $251.20M $233.30M $225.80M $300.40M $300.40M
Current Accrued Expenses $316.50M $324.80M – – –
Short-Term Debt and Capital Lease Obligation $628.10M $598.90M $620.70M $47.80M $47.80M
-Current Debt $627.50M $598.20M $620.10M $47.10M $47.10M
-Current Capital Lease Obligation $600,000.00 $700,000.00 $600,000.00 $700,000.00 $700,000.00
Current Deferred Liabilities $129.60M $127.90M $129.90M $127.90M $127.90M
Other Current Liabilities $366.60M $353.90M $409.70M $426.10M $426.10M
Total Non-Current Liabilities $2.48B $2.44B $2.46B $3.04B $3.04B
Long Term Accounts Payable and Other Payables $2.40M $5.60M $5.60M $7.50M $7.50M
Long Term Debt and Capital Lease Obligation $1.92B $1.86B $1.88B $2.46B $2.46B
-Long Term Debt $1.91B $1.86B $1.88B $2.46B $2.46B
-Long Term Capital Lease Obligation $1.60M $1.80M $1.70M $1.80M $1.80M
Non-Current Deferred Liabilities $302.90M $305.20M $302.70M $295.10M $295.10M
Other Non-Current Liabilities $257.00M $266.40M $277.20M $282.80M $282.80M
Total Equity $8.33B $8.24B $8.36B $8.24B $8.24B
Stockholders' Equity $8.33B $8.24B $8.36B $8.24B $8.24B
Capital Stock $21.80M $21.80M $21.80M $21.80M $21.80M
-Common Stock $21.80M $21.80M $21.80M $21.80M $21.80M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.00B $1.98B $1.99B $1.98B $1.98B
Retained Earnings $8.13B $7.70B $7.77B $7.64B $7.64B
Less: Treasury Stock -$1.44B -$1.10B -$1.09B -$995.20M -$995.20M
Gains/Losses Not Affecting Retained Earnings -$383.20M -$363.20M -$334.00M -$406.50M -$406.50M
Minority Interests $200,000.00 $200,000.00 $200,000.00 $200,000.00 $200,000.00
-Gross PPE – – – $3.91B $3.91B
-Accumulated Depreciation – – – -$1.83B -$1.83B

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $341.70M $182.80M $260.90M $796.10M $247.90M
Net cash flow from continuing operations $341.70M $182.80M $260.90M $796.10M $247.90M
Net Income from Continuing Operations $432.80M -$77.90M $130.80M $374.90M $84.60M
Depreciation & Depletion & Amortization $94.70M $95.40M $95.50M $377.40M $98.40M
Deferred Tax -$274.90M $43.50M $43.60M $135.20M $13.00M
Other Non-Cash Items $33.60M $30.20M $27.10M $45.60M -$70.80M
Change in Working Capital $55.50M $91.60M -$36.10M -$284.80M -$25.10M
Net cash flow from investing -$69.80M -$90.00M -$102.90M -$372.90M -$98.80M
Net Cash Flow from Continuing Investing Activities -$69.80M -$90.00M -$102.90M -$372.90M -$98.80M
Net PPE Purchase and Sale -$68.70M -$86.40M -$102.20M -$362.40M -$98.00M
Net Business Purchase and Sale -$1.10M -$3.60M -$700,000.00 -$10.50M -$800,000.00
Financing Cash Flow -$252.90M -$75.80M -$147.90M -$425.90M -$164.40M
Net Cash Flow from Continuing Financing Activities -$252.90M -$75.80M -$147.90M -$425.90M -$164.40M
Net Issuance Payments Of Debt $83.30M -$38.30M -$6.80M -$79.90M $28.00M
Net Common Stock Issuance -$339.20M -$15.50M -$92.50M -$290.10M -$196.80M
Proceeds from Stock Option Exercised $3.00M -$22.00M -$2.80M -$8.80M $4.40M
Net Other Financing Charges $0.00 $0.00 -$45.80M -$47.10M $0.00
Ending Cash Balance $154.90M $139.00M $125.00M $110.60M $110.60M
Net Change in Cash $19.00M $17.00M $10.10M -$2.70M -$15.30M
Beginning Cash Balance $139.00M $125.00M $110.60M $107.70M $124.90M
Effect of Exchange Rate Changes -$3.10M -$3.00M $4.30M $5.60M $1.00M
Free Cash Flow $273.00M $96.40M $158.70M $433.70M $149.90M
-Change in Receivables – – – -$120.30M –
-Change in Inventory – – – -$46.00M –
-Change in Payables and Accrued Expense – – – -$15.80M –
-Change in Other Current Assets – – – -$74.50M –
-Change in Other Current Liabilities – – – $18.60M –
-Change In Other Working Capital – – – -$46.80M –
Cash Dividends Paid – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on COO.

Sign in to join the discussion.

Scroll to Top